You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

m7824

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Heidelberg (89Zirconium-M7824, M7824)

Terminated
  • Non-Small Cell Lung Cancer
  • 89Zirconium-M7824
  • M7824
  • Heidelberg, Victoria, Australia
    Austin Health
Jan 13, 2023

Kaposi Sarcoma Trial run by the NCI (NHS-IL12, M7824)

Recruiting
  • Kaposi Sarcoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Urothelial Cancer, Bladder Cancer, Genitourinary Cancer Trial run by the NCI (M7824, M9241, Stereotactic body radiation therapy

Recruiting
  • Urothelial Cancer
  • +4 more
  • M7824
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Metastatic Prostate Cancer, Prostate Cancer, Prostate Tumor Trial run by the NCI (M7824, N-803, MVA-BN-Brachyury)

Recruiting
  • Metastatic Prostate Cancer
  • +4 more
  • M7824
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Head Neck Cancer, Head and Neck Tumors Trial run by the NCI (M7824, N803, TriAd vaccine)

Active, not recruiting
  • Head and Neck Cancer
  • Head and Neck Neoplasms
  • M7824
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Human Papilloma Virus, Cervical Cancer, Oropharyngeal Cancer Trial run by the NCI (M7824)

Active, not recruiting
Has Results
  • Human Papilloma Virus
  • +4 more
  • M7824
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 28, 2022

Histologically or Cytologically Confirmed Pancreatic Cancer, Unresectable or Borderline Resectable Pancreatic Cancer, Pancreatic

Terminated
Has Results
  • Histologically or Cytologically Confirmed Pancreatic Cancer
  • +4 more
  • M7824
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 19, 2022

Metastatic Cancer, Solid Tumors Trial run by the NCI (SX-682, M7824, MVA-BN-CV301)

Active, not recruiting
  • Metastatic Cancer
  • Solid Tumors
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 11, 2022

NSCLC Trial in Belgium, France, United States (Cisplatin, Carboplatin, Pemetrexed)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Fountain Valley, California
  • +18 more
Aug 10, 2022

Breast Cancer, Triple Negative Breast Cancer, HER2+ Breast Cancer Trial run by the NCI (Brachyury-TRICOM, Entinostat, M7824)

Terminated
Has Results
  • Breast Cancer
  • +4 more
  • Brachyury-TRICOM
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 9, 2021

Cancer Of Prostate, Prostate Tumors Trial run by the National Cancer Institute (NCI) (ADT, Prednisone, M7824)

Recruiting
  • Cancer Of Prostate
  • Prostate Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Worldwide (M7824)

Completed
Has Results
  • Biliary Tract Cancer
  • +2 more
  • M7824
  • Scottsdale, Arizona
  • +32 more
Oct 21, 2022

NSCLC Trial in Worldwide (M7824, Placebo, Durvalumab)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • M7824
  • +8 more
  • Orange, California
  • +103 more
Nov 24, 2022

Cervical Cancer Trial in Japan, Spain, United States (M7824, Carboplatin, Paclitaxel)

Completed
  • Cervical Cancer
  • M7824
  • +5 more
  • Stanford, California
  • +12 more
Jan 27, 2023